Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143794 |
| CAS No | NA |
| Mol.F. | C21H18D5N5O3S |
| Mol.Wt. | 430.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143795 |
| CAS No | 1219794-54-3 |
| Mol.F. | C4D10N2O |
| Mol.Wt. | 112.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143796 |
| CAS No | NA |
| Mol.F. | C8H7F3N4O5S2 |
| Mol.Wt. | 360.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143797 |
| CAS No | NA |
| Mol.F. | C15H16N2O4 |
| Mol.Wt. | 288.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143798 |
| CAS No | NA |
| Mol.F. | C15H18N2O4 |
| Mol.Wt. | 290.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143799 |
| CAS No | 2639422-25-4 |
| Mol.F. | C10H19N3O |
| Mol.Wt. | 197.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143800 |
| CAS No | NA |
| Mol.F. | C8H14N2O5 |
| Mol.Wt. | 218.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143801 |
| CAS No | NA |
| Mol.F. | C8H15N3O4 |
| Mol.Wt. | 217.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143802 |
| CAS No | NA |
| Mol.F. | C8H14ClN3O3 |
| Mol.Wt. | 235.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143803 |
| CAS No | NA |
| Mol.F. | C17H9D8FN4O5 |
| Mol.Wt. | 384.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143804 |
| CAS No | NA |
| Mol.F. | C34H39N7O7 |
| Mol.Wt. | 657.7 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143805 |
| CAS No | NA |
| Mol.F. | C12H12D5N3O2 |
| Mol.Wt. | 240.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143806 |
| CAS No | NA |
| Mol.F. | C10H19D4N3O3 |
| Mol.Wt. | 237.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143807 |
| CAS No | NA |
| Mol.F. | C10H18D4N4O4 |
| Mol.Wt. | 266.3 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143808 |
| CAS No | NA |
| Mol.F. | C10H22N215N2O4 |
| Mol.Wt. | 264.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143809 |
| CAS No | NA |
| Mol.F. | C10H23N215NO3 |
| Mol.Wt. | 234.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |